The original version of this story appeared in Quanta Magazine. If you want to solve a tricky problem, it often helps to get organized. You might, for example, break the problem into pieces and tackle ...

Abstract: When realizing multiagent optimal consensus control, it may encounter the situation that malicious agents transmit false information. Besides, due to the unreliability of information ...

The school year starts soon for many students, and ChatGPT has announced a new “study mode” that aims to prevent—or at least encourage against—students taking homework shortcuts. The mode is designed ...

Humanity’s quest for knowledge is our most striking feature. No other animal asks why or how things work, but humans aren’t content to enjoy the world as it is. We must ask why and tinker to make ...

The Democrats’ problems run deep, nearly everywhere. This is where voters shifted toward President Trump in each of the last three elections. And this is where voters shifted toward Democrats. By ...

Protect kids online from unwanted inappropriate content with the RANT method. When a kid stumbles on a scary video, his dad steps in to calm him and activate kid mode. But the real surprise is the ...

Kyle has a degree in Film, Television, and Cultural Studies and has loved video games for as long as he can remember. He's owned every PlayStation, dabbled with the occasional Xbox, and even owned a ...

I have some graphical problems when I open the game through QuickLauncher (wine maneged by xivlaucher), but not when I use Steam (Proton). I tried to force QuickLauncher to use the same Proton and ...

The editorial board is a group of opinion journalists whose views are informed by expertise, research, debate and certain longstanding values. It is separate from the newsroom. This editorial was ...

Days after Alabama scheduled its third execution by nitrogen hypoxia, lawyers for the latest prisoner set to die by this method have asked a federal judge to block the execution order. In a motion ...

Belzutifan, a hypoxia-inducible factor 2α inhibitor, showed clinical activity in clear-cell renal-cell carcinoma in early-phase studies. In a phase 3, multicenter, open-label, active-controlled trial, ...